Overview
VRTX market data
Price History
VRTX price chart · 1M
- O
- 505.01
- H
- 506.37
- L
- 496.44
- C
- 502.36
- Vol
- 35,030.00
Daily history from Jan 4, 2016
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $505.01
- Previous Close
- $503.56
- Day High
- $506.37
- Day Low
- $496.44
- 52 Week High
- $559.22
- 52 Week Low
- $401.11
- 7 Day Return
- -4.64%
- 30 Day Return
- -5.04%
- 90 Day Return
- +0.80%
- 1 Year Return
- +24.72%
- Daily Notional Volume
- $17.6M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 29.79 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $15.32 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.28 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 35.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $400.74 – $560.25 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $131.2B · P/B 6.16 · P/S 10.43.
Company News
10 captured
Novavax (NVAX) Surges 20.1%: Is This an Indication of Further Gains?Zacks Investment Research ·
Vertex Posts Positive Phase II Data on Kidney Disease DrugZacks Investment Research ·
Aerska Appoints Laura Sepp-Lorenzino to Scientific Advisory BoardGlobenewswire Inc ·